NCT05568147: Aspirin for Prophylaxis of TTP
- State
- Not started
- Phase
- Phase 2 and Phase 3
- People
- 100 planned
- Started
- 1 Oct 2022
- Primary completion
- 30 Sep 2027
- Arms
- Aspirin 100 mg daily
- Results
- None posted
- 5 Oct 2022: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Also known as Asa, Aspirin 100mg, Aspirin 100mg for 1-month (immediately after PCI), Aspirin 100mg for 6-month (6-month post PCI), Clopidogrel/acetylsalicylic acid component aspirin, CoPRIME aspirin alone, Duocover component aspirin, Duoplavin component aspirin, Durlaza, Measurin, Yosprala component aspirin.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.